{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T11:25:46Z","timestamp":1793273146914,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2021A1515010160"],"award-info":[{"award-number":["2021A1515010160"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2025A1515011810"],"award-info":[{"award-number":["2025A1515011810"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82174045"],"award-info":[{"award-number":["82174045"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012245","name":"Science and Technology Planning Project of Guangdong Province","doi-asserted-by":"publisher","award":["2023B1212060063"],"award-info":[{"award-number":["2023B1212060063"]}],"id":[{"id":"10.13039\/501100012245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Science, Technology and Innovation Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["JCYJ20220531103010022"],"award-info":[{"award-number":["JCYJ20220531103010022"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Science, Technology and Innovation Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["CYJ20220530141617039"],"award-info":[{"award-number":["CYJ20220530141617039"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.intimp.2025.114482","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T18:15:20Z","timestamp":1742235320000},"page":"114482","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Brusatol ameliorates intestinal mucosal injury in ulcerative colitis via activating IL-22\/STAT3 pathway"],"prefix":"10.1016","volume":"153","author":[{"given":"Ying","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxia","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixuan","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liting","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziren","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiannan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengquan","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weipeng","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhui","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijun","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youliang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2025.114482_bb0005","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41575-020-00360-x","article-title":"The four epidemiological stages in the global evolution of inflammatory bowel disease","volume":"18","author":"Kaplan","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.intimp.2025.114482_bb0010","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1053\/j.gastro.2019.04.016","article-title":"Environmental risk factors for inflammatory bowel diseases: an umbrella review of meta-analyses","volume":"157","author":"Piovani","year":"2019","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.intimp.2025.114482_bb0015","doi-asserted-by":"crossref","first-page":"384","DOI":"10.14309\/ajg.0000000000000152","article-title":"ACG clinical guideline: ulcerative colitis in adults","volume":"114","author":"Rubin","year":"2019","journal-title":"Am. J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.intimp.2025.114482_bb0020","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.cgh.2018.04.060","article-title":"Safety and efficacy of combination treatment with calcineurin inhibitors and Vedolizumab in patients with refractory inflammatory bowel disease","volume":"17","author":"Christensen","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"8","key":"10.1016\/j.intimp.2025.114482_bb0025","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/apt.16060","article-title":"Long-term safety of vedolizumab for inflammatory bowel disease","volume":"52","author":"Loftus","year":"2020","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.intimp.2025.114482_bb0030","series-title":"Advances in Traditional Chinese Medicine Treatment of Ulcerative Colitis, Beijing","author":"Han","year":"2014"},{"key":"10.1016\/j.intimp.2025.114482_bb0035","series-title":"China Pharmacopeia 2020","author":"N.P. Committee","year":"2020"},{"key":"10.1016\/j.intimp.2025.114482_bb0040","series-title":"Evaluation of the Efficacy of Brucea Javanica King and Medicine Herbal Compound in TNBS Induced Ulcerative Colitis, Zhejiang","author":"Lei","year":"2013"},{"issue":"3","key":"10.1016\/j.intimp.2025.114482_bb0045","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.bbrc.2015.03.124","article-title":"Brusatol inhibits the response of cultured beta-cells to pro-inflammatory cytokines in vitro","volume":"460","author":"Turpaev","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.intimp.2025.114482_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154323","article-title":"Brusatol suppresses the growth of intrahepatic cholangiocarcinoma by PI3K\/Akt pathway","volume":"104","author":"Chen","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.intimp.2025.114482_bb0055","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5561221","article-title":"Brusatol-enriched Brucea javanica oil ameliorated dextran sulfate sodium-induced colitis in mice: involvement of NF-kappaB and RhoA\/ROCK signaling pathways","volume":"2021","author":"Zheng","year":"2021","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.intimp.2025.114482_bb0060","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.intimp.2018.09.008","article-title":"Brusatol ameliorates 2, 4, 6-trinitrobenzenesulfonic acid-induced experimental colitis in rats: involvement of NF-kappaB pathway and NLRP3 inflammasome","volume":"64","author":"Zhou","year":"2018","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2025.114482_bb0065","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1080\/10717544.2017.1384521","article-title":"Characterization of brusatol self-microemulsifying drug delivery system and its therapeutic effect against dextran sodium sulfate-induced ulcerative colitis in mice","volume":"24","author":"Zhou","year":"2017","journal-title":"Drug Deliv."},{"issue":"1","key":"10.1016\/j.intimp.2025.114482_bb0070","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000458006","article-title":"Current and future targets for mucosal healing in inflammatory bowel disease","volume":"33","author":"Atreya","year":"2017","journal-title":"Visceral Med."},{"issue":"2","key":"10.1016\/j.intimp.2025.114482_bb0075","first-page":"534","article-title":"IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis","volume":"118","author":"Sugimoto","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2025.114482_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.766586","article-title":"IL-22 binding protein (IL-22BP) in the regulation of IL-22 biology","volume":"12","author":"Zenewicz","year":"2021","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2025.114482_bb0085","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.4049\/jimmunol.1402565","article-title":"Intestinal epithelial cell tyrosine kinase 2 transduces IL-22 signals to protect from acute colitis","volume":"195","author":"Hainzl","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2025.114482_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2016.00868","article-title":"Effect of a ropy exopolysaccharide-producing Bifidobacterium animalis subsp. lactis strain orally administered on DSS-induced colitis mice model","volume":"7","author":"Hidalgo-Cantabrana","year":"2016","journal-title":"Front. Microbiol."},{"issue":"2","key":"10.1016\/j.intimp.2025.114482_bb0095","article-title":"Ginsenoside metabolite compound K promotes recovery of dextran sulfate sodium-induced colitis and inhibits inflammatory responses by suppressing NF-kappaB activation","volume":"9","author":"Li","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.intimp.2025.114482_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105681","article-title":"Butyrate protects endothelial function through PPARdelta\/miR-181b signaling","volume":"169","author":"Tian","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"6","key":"10.1016\/j.intimp.2025.114482_bb0105","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1007\/s00394-019-02114-1","article-title":"Berberis lycium fruit extract attenuates oxi-inflammatory stress and promotes mucosal healing by mitigating NF-kappaB\/c-Jun\/MAPKs signalling and augmenting splenic Treg proliferation in a murine model of dextran sulphate sodium-induced ulcerative colitis","volume":"59","author":"Sharma","year":"2020","journal-title":"Eur. J. Nutr."},{"issue":"2","key":"10.1016\/j.intimp.2025.114482_bb0110","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/mi.2014.71","article-title":"An in vitro model of innate lymphoid cell function and differentiation","volume":"8","author":"Allan","year":"2015","journal-title":"Mucosal Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2025.114482_bb0115","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/s41385-022-00494-y","article-title":"Epithelial GPR35 protects from Citrobacter rodentium infection by preserving goblet cells and mucosal barrier integrity","volume":"15","author":"Melhem","year":"2022","journal-title":"Mucosal Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2025.114482_bb0120","doi-asserted-by":"crossref","first-page":"G1054","DOI":"10.1152\/ajpgi.00055.2011","article-title":"Occludin regulates macromolecule flux across the intestinal epithelial tight junction barrier","volume":"300","author":"Al-Sadi","year":"2011","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"3","key":"10.1016\/j.intimp.2025.114482_bb0125","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.bbamem.2007.07.012","article-title":"Adherens and tight junctions: structure, function and connections to the actin cytoskeleton","volume":"1778","author":"Hartsock","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.intimp.2025.114482_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111122","article-title":"The anti-hepatocellular carcinoma effect of Brucea javanica oil in ascitic tumor-bearing mice: the detection of brusatol and its role","volume":"134","author":"Wang","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2025.114482_bb0135","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13578-019-0309-8","article-title":"Brusatol, an NRF2 inhibitor for future cancer therapeutic","volume":"9","author":"Cai","year":"2019","journal-title":"Cell Biosci."},{"issue":"22","key":"10.1016\/j.intimp.2025.114482_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25225414","article-title":"Medicinal activities and nanomedicine delivery strategies for Brucea javanica oil and its molecular components","volume":"25","author":"Yoon","year":"2020","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.intimp.2025.114482_bb0145","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1242\/jcs.193482","article-title":"The mucosal barrier at a glance","volume":"130","author":"France","year":"2017","journal-title":"J. Cell Sci."},{"issue":"11","key":"10.1016\/j.intimp.2025.114482_bb0150","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/nri2653","article-title":"Intestinal mucosal barrier function in health and disease","volume":"9","author":"Turner","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2025.114482_bb0155","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.amjms.2018.11.011","article-title":"Correlation of intestinal mucosal healing and tight junction protein expression in ulcerative colitis patients","volume":"357","author":"Tan","year":"2019","journal-title":"Am J Med Sci"},{"issue":"3","key":"10.1016\/j.intimp.2025.114482_bb0160","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nri3608","article-title":"Intestinal epithelial cells: regulators of barrier function and immune homeostasis","volume":"14","author":"Peterson","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2025.114482_bb0165","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1146\/annurev-immunol-032414-112123","article-title":"Interleukin-22: Immunobiology and pathology","volume":"33","author":"Dudakov","year":"2015","journal-title":"Annu. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2025.114482_bb0170","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.immuni.2021.05.015","article-title":"ILC damage, and I\u2019ll repair it","volume":"54","author":"Sorini","year":"2021","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.intimp.2025.114482_bb0175","first-page":"1448","article-title":"Histopathologic features of inflammatory bowel disease are associated with different CD4+T cell subsets in colonic mucosal Lamina Propria","volume":"12","author":"Gui","year":"2018","journal-title":"J. Crohns Colitis"},{"issue":"1","key":"10.1016\/j.intimp.2025.114482_bb0180","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/mi.2013.31","article-title":"IL-22-producing CD4+ cells are depleted in actively inflamed colitis tissue","volume":"7","author":"Leung","year":"2014","journal-title":"Mucosal Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2025.114482_bb0185","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cell.2018.07.017","article-title":"Innate lymphoid cells: 10 years on","volume":"174","author":"Vivier","year":"2018","journal-title":"Cell"},{"issue":"7534","key":"10.1016\/j.intimp.2025.114482_bb0190","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nature14189","article-title":"The biology of innate lymphoid cells","volume":"517","author":"Artis","year":"2015","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.intimp.2025.114482_bb0195","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.immuni.2012.08.007","article-title":"Interleukin-22, the Guardian of the intestinal stem cell niche?","volume":"37","author":"Diefenbach","year":"2012","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.intimp.2025.114482_bb0200","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.immuni.2022.12.013","article-title":"Two faces: IL-22 effects prevail over defense against metastasis","volume":"56","author":"Qing","year":"2023","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.intimp.2025.114482_bb0205","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1038\/s41401-021-00781-7","article-title":"Baicalein ameliorates ulcerative colitis by improving intestinal epithelial barrier via AhR\/IL-22 pathway in ILC3s","volume":"43","author":"Li","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"issue":"9","key":"10.1016\/j.intimp.2025.114482_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/cells12091224","article-title":"IL-22-activated MUC13 impacts on colonic barrier function through JAK1\/STAT3, SNAI1\/ZEB1 and ROCK2\/MAPK signaling","volume":"12","author":"Breugelmans","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2025.114482_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.117874","article-title":"Shaoyao decoction improves damp-heat colitis by activating the AHR\/IL-22\/STAT3 pathway through tryptophan metabolism driven by gut microbiota","volume":"326","author":"Zhang","year":"2024","journal-title":"J. Ethnopharmacol."},{"issue":"40","key":"10.1016\/j.intimp.2025.114482_bb0220","doi-asserted-by":"crossref","first-page":"31335","DOI":"10.1074\/jbc.M005304200","article-title":"Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2\u20134 and IL-22R","volume":"275","author":"Xie","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.intimp.2025.114482_bb0225","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1074\/jbc.M007837200","article-title":"Identification of the functional Interleukin-22 (IL-22) receptor complex","volume":"276","author":"Kotenko","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"19","key":"10.1016\/j.intimp.2025.114482_bb0230","doi-asserted-by":"crossref","first-page":"5894","DOI":"10.1093\/emboj\/16.19.5894","article-title":"Identification and functional characterization of a second chain of the interleukin-10 receptor complex","volume":"16","author":"Kotenko","year":"1997","journal-title":"EMBO J."},{"issue":"3","key":"10.1016\/j.intimp.2025.114482_bb0235","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20192195","article-title":"The role of IL-22 in intestinal health and disease","volume":"217","author":"Keir","year":"2020","journal-title":"J. Exp. Med."},{"issue":"7","key":"10.1016\/j.intimp.2025.114482_bb0240","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1084\/jem.20082683","article-title":"STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing","volume":"206","author":"Pickert","year":"2009","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.intimp.2025.114482_bb0245","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.intimp.2004.01.010","article-title":"Temporal associations between interleukin 22 and the extracellular domains of IL-22R and IL-10R2","volume":"4","author":"Li","year":"2004","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2025.114482_bb0250","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/mi.2015.83","article-title":"IL-22BP is produced by eosinophils in human gut and blocks IL-22 protective actions during colitis","volume":"9","author":"Martin","year":"2016","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.intimp.2025.114482_bb0255","first-page":"534","article-title":"IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis","volume":"118","author":"Sugimoto","year":"2008","journal-title":"J. Clin. Invest."},{"issue":"7423","key":"10.1016\/j.intimp.2025.114482_bb0260","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nature11535","article-title":"IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine","volume":"491","author":"Huber","year":"2012","journal-title":"Nature"},{"issue":"6310","key":"10.1016\/j.intimp.2025.114482_bb0265","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1126\/science.aah5903","article-title":"A pathogenic role for T cell-derived IL-22BP in inflammatory bowel disease","volume":"354","author":"Pelczar","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.intimp.2025.114482_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119195","article-title":"Mechanisms and regulation of IL-22-mediated intestinal epithelial homeostasis and repair","volume":"271","author":"Patnaude","year":"2021","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.intimp.2025.114482_bb0275","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/MIB.0000000000000267","article-title":"High suppressor of cytokine signaling-3 expression impairs STAT3-dependent protective effects of interleukin-22 in ulcerative colitis in remission","volume":"21","author":"Xu","year":"2015","journal-title":"Inflamm. Bowel Dis."},{"issue":"25","key":"10.1016\/j.intimp.2025.114482_bb0280","doi-asserted-by":"crossref","first-page":"7490","DOI":"10.7150\/thno.35015","article-title":"Thymopentin ameliorates dextran sulfate sodium-induced colitis by triggering the production of IL-22 in both innate and adaptive lymphocytes","volume":"9","author":"Cao","year":"2019","journal-title":"Theranostics"},{"issue":"4","key":"10.1016\/j.intimp.2025.114482_bb0285","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00535-017-1401-7","article-title":"Clinical importance of IL-22 cascade in IBD","volume":"53","author":"Mizoguchi","year":"2018","journal-title":"J. Gastroenterol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925004722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925004722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:49:37Z","timestamp":1762552177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925004722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":57,"alternative-id":["S1567576925004722"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114482","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brusatol ameliorates intestinal mucosal injury in ulcerative colitis via activating IL-22\/STAT3 pathway","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114482","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114482"}}